Cambridge Capital Group
The first private angel investment group in Cambridge - investing in technology start-ups across the UK's Golden Triangle of Cambridge, London and Oxford for over 18 years.
|Address:||The Bradfield Centre, UNIT 184 Cambridge Science Park, Cambridge|
|Membership type:||Professional Individual and Corporate < 5 (£50+VAT pa)|
Cambridge Capital Group (CCG) is a private investor group focused on early-stage disruptive technology businesses. We seek to invest in companies that have the potential to deliver attractive capital returns within 5-7 years. The Group was founded in 2000 and its unique structure and focus has proved highly successful for members. CCG has a well established position in the Cambridge and wider high technology investment market, built up over 18 years.
The investment process is coordinated and deal flow is managed although angel members act on their own account. During 2016 our members enjoyed four successful exits including the highly profitable sale of Swiftkey to Microsoft for $250m.
Members are successful entrepreneurs; retired professionals; private investment companies and family trusts. We have more than 80 members with a mix of local, UK and offshore investors. New applications from prospective members are welcome. Four corporate sponsors support our programme of quarterly presentation events.
Lightpoint Medical, a leader in intraoperative molecular imaging and sensing, announced that the company has secured £5 million in equity finance to fuel the company’s commercial growth. Investors included existing and new shareholders Cambridge Capital Group, Venture Founders, Coutts Investment Club, Envestors, Fund Twenty8, SyndicateRoom, and Oxford Technology.
7 December 2018Read in full
Cambridge Capital Group (CCG) is in the final planning stages for a delegation from Cambridge to Chile next month (11-15 March).
5 February 2014Read in full
The new UK Business Angels Association has launched a portal to promote angel investing. Cambridge Capital Group is a member of the national trade body for British angel investors.
3 January 2013Read in full
Angel investors are invaluable for bridging the ‘valley of death’ between seed corn funding and institutional investment, according to Prof Andrew Stewart Coats, Norwich Research Park CEO. Entrepreneurs, scientists and technologists are being given the opportunity to meet business angels at the next Venta meeting on 26th April 2012.
12 March 2012Read in full
Now is an exciting time for angel investment: there are many interesting opportunities emerging from the research community and tax incentives from Government for those that support early-stage businesses. The Norwich Research Park is hosting an angel event on 16th November to launch its new Venta programme.
1 November 2011Read in full